The increase in ROS levels affects the expression and processing of AβPP, initiating Aβ accumulation and the activation of various signaling pathways in brain tissue, further contributing to the development of AD (Yuan et al., 2018; Figure 2). This evidence concerns the gene APP and Alzheimer disease.